NCT02509520

Brief Summary

Elderly patients who experience a prolonged ICU stay are at high risk for developing post intensive care unit syndrome (PICS), a serious medical condition manifested by loss of muscle mass, weakness, malnutrition and neurocognitive decline. PICS often leads to chronic disability, prolonged mechanical ventilation and the need for costly extended stays in long term care facilities (LTCs). The investigators' preliminary study shows attempts at rehabilitating patients who have already developed PICS are minimally effective, resulting in only modest improvements in functionality. This project will determine the effects of mobility-based physical rehabilitation (MPR) combined with neuromuscular electric stimulation (NMES) and high protein supplementation (HPRO) early in a patients ICU stay on preventing PICS related musculoskeletal and functional deficits, and improving clinical outcomes.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2015

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

July 21, 2015

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 28, 2015

Completed
10.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

July 3, 2025

Status Verified

March 1, 2025

Enrollment Period

11 years

First QC Date

July 21, 2015

Last Update Submit

June 29, 2025

Conditions

Keywords

Nutritional supplementationNeuromuscular Electric StimulationICU acquired weaknessPost ICU Syndromesarcopenia

Outcome Measures

Primary Outcomes (4)

  • Muscle mass

    Muscle mass as measured by lower extremity muscle volume

    14 days

  • Global body strength

    Muscle group strength as measured by hand held dynamometer and by hand grip strength

    14 days

  • Mobility status

    Outcome as measured by combined 6 minute walk distance and gait speed

    14 days

  • Short Physical Performance Battery

    Short Physical Performance battery will be assessed at baseline and at 7 and 14 days.

    14 days

Secondary Outcomes (4)

  • Time to weaning

    14 days

  • ICU/Hospital length of stay

    14 days

  • Discharge disposition

    30 days

  • Weaning success

    14 days

Study Arms (2)

Mobility-based Physical Rehab (MPR)

NO INTERVENTION

ICU control group receiving only mobility based rehabilitation (MPR).

MPR and Neuromuscular Stimulation and HPRO

ACTIVE COMPARATOR

ICU group receiving mobility based rehabilitation and NMES and High protein supplementation.

Dietary Supplement: MPR and High Protein Supplement (HPRO) and Neuromuscular Electric Stimulation (NMES)

Interventions

The MPR provides strength and cardiopulmonary endurance training, which consist of exercises to promote function movements. Intensity is based on patient's hemodynamic responses and subjective report using Modified Borg Dyspnea Scale. Intensity, duration, or type of activity will be modified each session to achieve a moderately intense physiologic response. The NMES protocol requires self-adhesive surface electrodes be placed on quadriceps muscles and lower leg bilaterally, twice daily. This protocol is based on prior NMES protocols used to stimulate muscle protein synthesis in older diabetic patients, preserve muscle mass in intensive care patients and increase strength in older adults after knee replacement. The HPRO intervention is based on caloric needs, calculated using validated equations to maintain positive nitrogen balance. Protein will be supplemented as isolated amino acids twice/day to deliver \~15g of essential amino acids per serving, with a goal of 1.6 g/kg/day.

MPR and Neuromuscular Stimulation and HPRO

Eligibility Criteria

Age45 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 45 years
  • Respiratory insufficiency requiring mechanical ventilation (MV)
  • ICU presentation \< 6 days
  • Patient or legally authorized representative able to provide written or witnessed verbal informed consent in English
  • All four limbs intact and mobile
  • Eligible for and able to participate in physical therapy
  • Pre admission Barthel Index \>70

You may not qualify if:

  • Acute kidney injury with a glomerular filtration rate \< 30 ml/min
  • Diagnosis of severe organ dysfunction including end stage liver disease or cirrhosis
  • Diagnosis of active cancer
  • Acute or chronic organ transplant rejection
  • Exceedingly high mechanical ventilator settings (FiO2\>60%, PEEP\>12) or alternative modes of mechanical ventilation (inverse ratio pressure control, airway pressure release ventilation)
  • Severe functional impairment or physical impairment to rehabilitation
  • On high dose vasopressor agents (\> 5mcg of norepinephrine or equivalent)
  • Liver function tests \> 2.5 x normal limits (normal reference ranges include AST between 10 and 40 units/L or ALT between 7 and 56 units/L)
  • Chronic dementia or cognitive impairment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

U of Maryland, Baltimore, Professional Schools IRB

Baltimore, Maryland, 21201, United States

Location

Related Publications (1)

  • Verceles AC, Serra M, Davis D, Alon G, Wells CL, Parker E, Sorkin J, Bhatti W, Terrin ML. Combining exercise, protein supplementation and electric stimulation to mitigate muscle wasting and improve outcomes for survivors of critical illness-The ExPrES study. Heart Lung. 2023 Mar-Apr;58:229-235. doi: 10.1016/j.hrtlng.2022.11.013. Epub 2022 Dec 5.

MeSH Terms

Conditions

Muscle WeaknessCritical IllnessSarcopenia

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsDisease AttributesMuscular AtrophyAtrophyPathological Conditions, Anatomical

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 21, 2015

First Posted

July 28, 2015

Study Start

May 1, 2015

Primary Completion

May 1, 2026

Study Completion

May 1, 2026

Last Updated

July 3, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations